Neurology 1506 - Neurology Alert - Jun 01, 2011

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders

Authors

Steven Karceski, MD
Director of Clinical Trials
Cornell Comprehensive Epilepsy Center
Weill Cornell Medical College

Melissa J. Nirenberg, MD, PhD
Assistant Professor, Neurology and Neuroscience
Weill Cornell Medical College

Joseph E. Safdieh, MD
Assistant Professor of Neurology
Weill Medical College, Cornell University

Wendy S. Vargas, MD
Pediatric Neurology Fellow
Weill Cornell Medical College

Steven Weinstein, MD

Director of the Pediatric Comprehensive Epilepsy Program
Weill Cornell Medical College

Subjects:

  • Psychogenic Nonepileptic Seizures
  • Amyloid Neuropathy
  • Strep-induced Movement Disorders: Should the Term 'PANDAS' Be Extinct?
  • Treatment of Chronic Fatigue Syndrome
  • Detecting Concussion in Boxers and Mixed Martial Arts Fighters
  • Stroke Alert: A Review of Current Clinical Stroke Literature

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, reports no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study. Assistant editor Michael Rubin, MD, FRCP(C), authors Melissa J. Nirenberg, MD, PhD, Joseph E. Safdieh, MD, Wendy S. Vargas, MD, and Steven Weinstein, MD, and peer reviewer M. Flint Beal, MD, report no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study.Author Steven Karceski, MD is on the speakers bureau for GlaxoSmithKline, Cyperonics, and Pfizer; and receives research support from Novartis and Cyberonics.

Copyright 2011 AHC Media LLC. All rights reserved.